CoreCap Advisors’s Astrana Health ASTH Stock Holding History

CoreCap Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15K	Buy	+423	New	+$16.7K	﹤0.01%	1922

Other funds holding ASTH

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

CoreCap Advisors's ASTH Position: Q3 2026 in Review

CoreCap Advisors opened a new position in Astrana Health (ASTH) in Q3 2026: 423 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1922 among its holdings.

11 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

CoreCap Advisors held 423 shares of Astrana Health worth $15K as of Q3 2026.
Astrana Health was a new CoreCap Advisors position in Q3 2026.
Astrana Health made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1922 holding.
11 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.